Lilly Offering $35 Insulin Co-Pays During Pandemic

Eli Lilly & Co. Tuesday unveiled a program offering $35 co-pays for its key insulin products during the coronavirus crisis.
The Indianapolis drug maker said the Lilly Insulin Value Program allows anyone with commercial insurance and those without insurance to fill their monthly prescriptions for $35.
Eli Lilly said the program covers most of its insulins, including all Humalog formulations.
The company in early March said it doesn’t expect any shortages of its insulin products during the pandemic.

https://www.marketscreener.com/ELI-LILLY-AND-COMPANY-13401/news/Eli-Lilly-and-Offering-35-Insulin-Co-Pays-During-Pandemic-30376571/